Activity
| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3 actions
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fetal anomalies v8.26 | OPA1 | Ida Ertmanska commented on gene: OPA1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fetal anomalies v8.25 | OPA1 | Louise Carr reviewed gene: OPA1: Rating: AMBER; Mode of pathogenicity: ; Publications: 26561570, 39233737; Phenotypes: Mitochondrial DNA depletion syndrome 14B (cardioencephalomyopathic type), OMIM:616896, Mitochondrial DNA depletion syndrome 14A (encephalomyopathic type), OMIM:621481; Mode of inheritance: BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fetal anomalies v8.23 | OPA1 |
Ida Ertmanska gene: OPA1 was added gene: OPA1 was added to Fetal anomalies. Sources: Expert Review Amber,NHS GMS Mode of inheritance for gene: OPA1 was set to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal Publications for gene: OPA1 were set to 26561570; 39233737 Phenotypes for gene: OPA1 were set to Mitochondrial DNA depletion syndrome 14B (cardioencephalomyopathic type), OMIM:616896; Mitochondrial DNA depletion syndrome 14A (encephalomyopathic type), OMIM:621481 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||